|
|
||||||||
1From the School of Natural Sciences, Parramatta Campus, University of Western Sydney, Sydney, New South Wales, Australia; and 2Department of Ophthalmology and Graduate School of Biomedical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
| Abstract |
|---|
|
|
|---|
METHODS. Tlc was purified from human tears by size exclusion chromatography followed by ion exchange chromatography. Three additional samples of the Tlc were prepared by lipidation, delipidation, and relipidation. The lipids extracted from the purified Tlc were analyzed by HPLC-MS followed by fragmentation. Adsorption of these different forms of Tlc to a human Meibomian lipid film spread on the surface of an artificial tear buffer in a Langmuir trough were observed by recording changes in the pressure with time (
-T profile) and monitoring the appearance of the film microscopically. These results were compared with similar experiments using a bovine Meibomian lipid film.
RESULTS. The results indicated that Tlc binds slowly to a human Meibomian lipid film compared with lysozyme or lactoferrin, even at 37°C. The adsorption of Tlc to a human Meibomian lipid film was very different from its adsorption to a bovine Meibomian lipid film, indicating the nature of the lipids in the film is critical to the adsorption process. Similarly, the different forms of Tlc had quite distinct adsorption patterns, as indicated both by changes in
-T profiles and the microscopic appearance of the films.
CONCLUSIONS. It was concluded that human Tlc was capable of adsorbing to and penetrating into a Meibomian lipid layer, but this process is very complex and depends on both the types of lipids bound to Tlc and the lipid complement comprising the Meibomian lipid film.
34°C.9 A similar result was obtained at
24°C using
24 µg/mL Tlc.10 Tlc has also been shown to adsorb to phospholipid films held at pressures up to
30 mN/m, and more readily adsorb to those held at lower initial surface pressures. Previously, we have shown that apo-Tlc penetrated more readily than holo-Tlc into a bovine Meibomian lipid film held at 10 mN/m at 20°C.11 These data all point to Tlc adsorbing to and penetrating into the Meibomian lipid layer of a tear film. Although indicative of Tlc having a role at the surface of the tear film, a better understanding could be achieved by using conditions that emulate the human tear film. This has been attempted in this study where adsorption of Tlc to a human Meibomian lipid film at 20°C has been examined and compared with adsorption of Tlc to films held at 37°C. Similar experiments were then carried out using delipidated Tlc and Tlc that had been lipidated with a fluorescent cholesterol derivative (NBD-cholesterol) to investigate possible release of lipids to the Meibomian lipid film. | Materials and Methods |
|---|
|
|
|---|
NBD-cholesterol (25-{N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-methyl]amino}-27-norcholesterol) and NBD-phosphatidylcholine (1-acyl-2- [12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] dodecanoyl]-sn-glycero-3-phospho-choline) were obtained from Avanti Polar Lipids Inc. (Alabaster, AL). Chloroform used for dissolving lipids was HPLC grade (LabScan, Kings Park, NSW, Australia). There was no surface activity associated with this solvent. Ion exchange purified water (Milli-Q; Millipore, Billerica, MA) with a resistance of 18.2 M
was used in all experiments. An artificial tear (AT) buffer that emulates ion concentrations in human tears12 was prepared (NaCl, 6.6 g/L; KCl, 1.7 g/L; NaHCO3, 1.4 g/L; CaCl2 · 2H2O, 0.15 g/L, NaH2PO4 · H2O, 0.1 g/L; MOPS, 4.18 g/L [pH 7.4]) and used as the subphase in the surface pressure experiments described below.
Collection of Meibomian Lipids
The research protocol for collection of human Meibomian lipids included informed consent and was approved by the local (Biomedical) Human Research Ethics Advisory Panel reference number 074012. The protocol was in accordance with the World Medical Association Declaration of Helsinki for "Ethical Principles for Medical Research Involving Human Subjects" (October 2000). Subjects had no signs or symptoms of ocular disease, nor were the subjects on any medication. Human Meibomian lipids were expressed from eyelids by applying pressure using two opposed cotton buds. This is known as hard expression and the Meibomian lipids appear as a paste on the eyelid margin. It should be noted that others have reported that gentle squeezing of Meibomian glands from disease-free patients results in an oily secretion, and a viscous solution from patients with Meibomianitis.13 14 The pasty excretion acquired in our case is not to be confused with the latter and represents the normal appearance of Meibomian lipids that are hard expressed from the glands of normal patients. The extracted Meibomian lipids were collected from the lid margin with a stainless steel spatula and dissolved in chloroform. A number of different samples were collected from three subjects until a total of
5 mg was obtained over a two-week period. These samples were pooled to provide enough for all experiments in this study. Before pooling, samples were kept at –80°C. The pooled sample was dried, weighed and reconstituted at 1 mg/mL in chloroform. Bovine Meibomian lipids were collected as previously described15 16 and was in accordance with the ARVO Animal Statement.
Purification of Tlc from Human Tears, Its Lipidation, Delipidation, and Relipidation
Collection of tears was approved by the local human ethics committee and was in accordance with the Declaration of Helsinki for human experimentation. After obtaining informed consent, reflex tears were collected from a single healthy pre-menopausal female volunteer over a number of separate occasions during an eight-week period, at different times during the day. Typically, 100 to 300 µL of reflex tears were collected in a single session and these samples were stored at –80°C until a volume of 500 µL had been collected, after which they were processed to minimize deterioration during storage. A total of 6 mL of tears were used for these experiments. The procedure for purification of Tlc from this sample was similar to that described previously.1 9 17 18 Tear proteins were initially separated by size exclusion chromatography using a cross-linked agarose based column (Superose 12 10/300 GL column using an AKTA FPLC system; GE Healthcare, Rydalmere, NSW, Australia). The mobile phase was 50 mM sodium phosphate buffer/0.15 M NaCl (pH 7). Before loading onto the FPLC column, tear samples were centrifuged at 4000g for 5 minutes and the supernatant was loaded onto the column via a 0.22 µm filter (Millipore). Chromatography was performed at a flow rate of 0.3 mL/min and 0.5 mL fractions were collected. This meant that the protein was under relatively low pressure through the column and less likely to denature. Absorbance was measured at 280 nm. Fraction analysis by SDS-PAGE revealed that Tlc eluted earlier than expected based on molecular weight, and always co-eluted with lactoferrin (LF) and lysozyme (LZ; Fig. 1 ). Appropriate fractions were pooled and concentrated using a 3 kDa ultrafilter (Vivaspin; Sartorius, Aubagne, France). Ion exchange chromatography was carried out using a mini H spin column (Vivapure S; Sigma-Aldrich). The column was equilibrated with 25 mM sodium phosphate buffer (pH 7.2) by loading 400 µL onto the spin column and centrifuging at 2000g for 5 minutes. A protein sample (400 µL) was loaded onto the equilibrated spin column and spun at 2000g for 5 minutes, and the wash containing Tlc was collected. This was repeated until the entire sample was loaded. The column was washed twice with 400 µL of 25 mM sodium phosphate buffer (pH 7.2) to obtain any further Tlc. To release and recover proteins such as LZ and LF, which adsorb to the ion exchange membrane, 25 mM sodium phosphate (pH 7.2) containing 1M NaCl was applied to the column and centrifuged at 2000g for 5 minutes.
|
To microscopically monitor the performance of Tlc at an air liquid interface, various forms of Tlc were prepared by loading it with a fluorescently tagged form of cholesterol (NBD-cholesterol). Cholesterol was chosen because Tlc has been shown to bind cholesterol1 and cholesterol is a neutral lipid. For the purposes of these experiments, the purified Tlc was assumed to be carrying a mixture of lipids from the tears and will be referred to as purified Tlc. This was loaded with NBD-cholesterol without prior delipidation using previously described methods.6 19 This sample will be referred to as lipidated Tlc. The expectation was that there would be some apo-Tlc in this sample and it would become loaded with NBD-cholesterol, and some of the lipids in holo-Tlc would be replaced by NBD-cholesterol. Another sample of the purified Tlc was delipidated by extraction with a mixture of chloroform:methanol (2:1).1 This will be known as delipidated Tlc. The lipid extracts were dried and stored at –80°C for analysis. Some of the delipidated Tlc was loaded with NBD-cholesterol using the same method as used for the lipidation above; this will be known as relipidated Tlc.
Analysis of the Lipid Extracts from Human Tlc
The extracts were reconstituted in an n-hexane:propan-2-ol (1:1, v/v) solvent mixture (HP) flushed with nitrogen, and stored in a glass vial at –80°C. The samples were readily soluble in the solvent and no precipitate was observed, indicating no salts, peptides, or carbohydrates were present in the samples. Analyses were performed as described previously.20 21
Two separation procedures were used: the first was optimized for nonpolar lipids, and the second was designed to separate polar lipids. The nonpolar lipids were separated by normal phase (NP) high pressure liquid chromatography using a 3.2 x 150 mm, 5 µm column (Lichrosphere Diol; Phenomenex, Torrance, CA). An HPLC system (Alliance 2695 HPLC Separations Module; Waters Corp., Milford, MA) was used throughout the study. Isocratic elution of the compounds was performed at 30°C and a flow rate of 0.3 mL/min using a n-hexane:propan-2-ol:acetic acid (HPA; 949:50:1, v/v/v) solvent mixture. The whole effluent was directed to an ion trap mass spectrometer (LCQ Deca XP Max; Thermo Electron Corp., San Jose, CA) using an atmospheric pressure chemical ionization (APCI) ion source and analyzed in both positive and negative ion modes. The system was controlled using data system software (XCalibur; Thermo Electron Corp.). The retention times and m/z values of the analytes were compared with those of authentic lipid standards. Between 1 and 30 µL of the sample solutions were injected. No attempts to quantify the analytes were made.
The lipid components of the extracts were also separated by NP HPLC using a 3.2 x 150 mm, 5 µm column (Lichrosphere Si-60 silica gel HPLC; Supelco, Bellefonte, PA). The elution of polar lipids (both authentic standards and unknowns in the sample) was detected using electrospray ionization (ESI) mass spectrometry in the positive ion mode. The separation was performed using gradient elution of the analytes by n-hexane/propan-2-ol/5mM aqueous ammonium formate mixtures at 30°C. For structural elucidation of the putative lipid components, samples were analyzed using direct infusion protocols.20 21
Adsorption of Tlc to Human and Bovine Meibomian Lipid Films
A dual barrier Langmuir trough (NIMA 102M; Nima Technology Ltd, Coventry, UK) was used for the protein adsorption experiments. The principle of this instrumentation (see Ref. 22 for more details of this technique) is that the interaction or the presence of surface active molecules can be measured by an increase in surface pressure over that of water (or buffer) alone. Typically, a small amount of the surfactant of interest (Meibomian lipids in this case) is spread on an aqueous buffer subphase between two movable barriers which are at maximum distance from each other. Initially the number of molecules spread on the surface between the barriers is such that there is no interaction between these molecules and so there is no change in surface pressure. The two barriers are then moved toward each other, decreasing the surface area between the barriers. The consequence is that the surfactant molecules are pushed closer and closer together and start to interact with each other. This is seen as an increase in pressure (
) which is measured using a Wilhelmy plate (Whatman, Chr 1 filter paper) connected to a Wilhelmy balance. For these experiments, 25 µL of human Meibomian lipids dissolved in chloroform (1 mg/mL) were initially spread between the barriers onto a subphase (
80 mL of AT buffer, which had had the surface swept clean). The barriers were then moved toward each other from their maximum surface area (80 cm2) until a surface pressure of 10 mN/m was achieved. Although other initial surface pressures could have been used, this was chosen for comparison with previous protein adsorption experiments.11 16 This surface area was kept constant during the adsorption experiments. To test protein adsorption 50 µL of Tlc (1.2 mg/mL in 10 mM PBS; 0.9% NaCl [pH 7.4]) was injected into the subphase outside the barriers, and
monitored over time (
-T). The expectation was that as more molecules adsorbed to the surface, the molecules on the surface would rearrange and hence
would gradually increase until equilibrium was reached.
After an equilibrium pressure (
eq) was attained, a series of isocycles were carried out on the protein adsorbed Meibomian lipid film. This is done by moving the barriers toward each other (compressing the film) and then moving them apart (expanding the film) while recording
-A profiles. Each experiment was repeated at least three times. The maximum pressure (
max) when the barriers were closest together was always within ± 0.5 mN/m if the same volume of a particular sample were added to the trough. The temperature of the trough was maintained by a circulatory water jacket connected to a thermostat. The relative humidity in the laboratory ranged from 35% to 55%, but no differences were found when the same experiments were carried out at different humidity.
Fluorescence Microscopy and Photography of the Surface Films
To microscopically examine changes in the Meibomian lipid film due to adsorption of Tlc, Meibomian lipids were doped with a fluorescently tagged phosphatidylcholine (1% NBD-PC). No significant differences were found in the
-T profiles with or without the fluorescent tag. Similarly, for adsorption of delipidated Tlc to Meibomian lipid film, NBD-PC was mixed with Meibomian lipids. For monitoring lipidated and relipidated Tlc adsorption, Meibomian lipid films without any fluorescent tag were used. In these cases, any fluorescence observed in the film was the result of NBD-cholesterol which had been loaded into the Tlc. Films were observed at 400x using an epifluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany) with appropriate excitation and barrier filters. Digital images of the surface films were recorded using an EMCCD camera (back-illuminated, DV887ECS-BV; Andor Ixon, South Windsor, CT) with a shutter speed of 10–2 s or less.
| Results |
|---|
|
|
|---|
18 kDa (Fig. 2) and there was no indication of a band at
36 kDa even in the silver stained gels, which would have indicated a dimeric form of the protein. Two-dimensional gel electrophoresis showed that there were probably two isoforms and that the protein had an isoelectric point of
pH 5 (Fig. 2B) , which is consistent with the literature.23 Western blot was also used to confirm that this band was Tlc (data not shown).
|
18 kDa, a faint band could be seen at
34 kDa in the overloaded silver stained gel that could indicate a dimeric form of Tlc (Fig. 2D) . It should be noted that the possible dimeric forms mentioned here and above would be due to noncovalent dimerization, because the gel was run under reducing conditions. Similarly, under these conditions dimeric forms of Tlc due to cystine formation would not have been detected.
Lipids Obtained from Delipidation of Tlc
Under the conditions of NP HPLC APCI analysis of the lipid extract, a single main HPLC peak with a retention times (RT) of
4.4 minutes (Fig. 3A) was produced. Its elution time was in the region of tri- and di-acyl glycerols rather than wax esters (RT
3.2 min), cholesterol esters (RT
3.4 min) and free cholesterol (RT
7.4 min), which are typical components of Meibomian lipids.20 21 Using positive ion mode the main ions m/z were 663.3, 637.1 (minor), 607.4, 593.5, 579.4, 565.4, 551.4, and 537.4 (Fig. 3B) . To elucidate their possible structures, these peaks were fragmented, and some had either unexpected or very complex fragmentation patterns. For instance, a m/z of 663 could have been an ion of dehydrated diarchidoylglycerol ([M – H2O + H]+). However, sequentional MSn fragmentation in the positive ion mode at the relative collision energy of 40 V produced a series of fragments differing by 56 atomic mass units (amu): 663 (MS1)
607 (MS2)
551 (MS3)
495 (MS4)
439 (MS5)
383 (MS6)
327 (MS7). This was attributed to a potential neutral loss of six [(CH3)2C
CH2] fragments consistent with fragmentation studies of Irgafos24 (a contaminant from plasticware) rather than diarachidonoylglycerol. This was confirmed in a second sample, in which the lipids of the Tlc sample had been extracted in plasticware rather than glass. In this case, the strongest m/z signal was 663; there was also a strong signal at 637. Fragmentation of these gave the same pattern as above (not shown). The peaks 663 and 495 co-eluted, indicating that the 495 peak was also derived from Irgafos. Similarly, in the negative ion mode, the peak displayed a spectrum with a prominent ion at m/z 473.5 oxidized Irgafos (data not shown).
|
561 (579 – H2O) + 327 + 267 + 239 + 221 (239 – H2O). When plotted as two single ion chromatograms detected in one HPLC MS experiment, ions 663 and 579 eluted as two clearly different HPLC peaks (Fig. 3C) .The m/z peak of 607 gave a complex pattern indicating that it was clearly composed of two different isobaric compounds, one which produced ions m/z 551 and 495 (loss of 56 amu described above consistent with it being an Irgafos contaminant) while the other gave strong signals m/z 327, 285, 267 (285 – H2O), and 249, and a much weaker signal m/z 589 (607 – H2O). Signals consistent with phospholipids were not detected in the samples using HPLC-MS and direct infusion MS protocols described previously.20 21
Compression and Expansion Isocycles of Tlc Samples (Purified, Lipidated, Delipidated, and Relipidated) Applied to the Surface of the Subphase
Purified Tlc (35 µL) dissolved in AT buffer (1 mg/mL) was spread on the buffer surface (no lipids present) between the barriers and allowed to equilibrate for five minutes. Isocycles were then carried out until there was no further change in the
-A curve (equilibrium). Irrespective of the temperature, the equilibrium
-A curve (after 100 cycles) compared with the initial curve showed an increase in
max (maximum pressure recorded during compression) from 18 mN/m to 25 mN/m, and take-off (the area where
first increased above 0 mN/m during compression) increased. There was little difference in the overall shape of the initial and equilibrium curves. Similar studies were done with lipidated, delipidated and relipidated Tlc (Fig. 4) . In all cases, the
-A curves were very similar, being relatively linear during compression, and there was more hysteresis during expansion at 20°C than at 37°C. This latter finding would be expected with increased molecular mobility at the higher temperature; the molecules rearrange more quickly resulting in decreased viscosity. Notably, the lipidated and relipidated samples show more hysteresis than the delipidated sample. The overall lack of differences in these curves indicate that there was little unfolding or rearrangement of the molecules on the surface.
|
max was consistently higher for human Meibomian lipids, and there was some hysteresis on expansion of the human Meibomian lipid film. The apparently small difference in
max between human and bovine Meibomian lipids (20 mN/m versus 18 mN/m) was consistently observed. To obtain a
max of 20 mN/m with bovine lipids, 40 µL of 1 mg/mL had to be spread on the surface (nearly double the number of molecules). Seeding the film with NBD-PC did not alter these
-A curves. At 37°C,
max was reduced and there was less hysteresis in the human Meibomian lipid film (Fig. 5) .
|
=7). These gray patches coalesced and condensed into nonfluorescent patches. At
max, the film was again relatively amorphous interlaced with nonfluorescent wispy patches (Fig. 6) .
|
Similar experiments were carried out using either purified human Tlc which had been lipidated with fluorescently tagged cholesterol (NBD-cholesterol; lipidated Tlc) or delipidated Tlc which had similarly been loaded with NBD-cholesterol (relipidated Tlc). When lipidated or relipidated Tlc was used, no fluorescent tag was used in the Meibomian lipids, hence the fluorescence observed microscopically came from the NBD-cholesterol that was loaded into the Tlc. Theoretically, this could enter the film either bound to Tlc or as free cholesterol.
Purified Tlc injected into the subphase outside the barriers caused little change to
inside the barriers when there was no lipid film on the surface (Fig. 7) . A bovine Meibomian lipid film spread between the barriers and held at
init = 10 mN/m showed a little change in surface pressure if purified Tlc were injected into the subphase outside the barriers. By contrast, adsorption to a human Meibomian lipid film at 20°C or 37°C held at
init = 10 mN/m was substantial leading to a
eq = 20 mN/m and 30 mN/m respectively. Adsorption was relatively slow at 20°C, but faster at 37°C, and the adsorption curve in both cases was linear. Once equilibrium was attained,
-A isocycles were performed. These showed much greater
max and much greater hysteresis than for films of Meibomian lipids alone (Fig. 5) . The
max obtained at 20°C was much greater than that obtained at 37°C.
|
= 10 mN/m was relatively amorphous, exhibiting a few small dark (nonfluorescent) patches. After injection of Tlc into the subphase, the film became patchy, presumably as the Tlc (nonfluorescent) penetrated the surface. There was a simultaneous increase in
. With further time, dark patches appeared in the film that became progressively larger. Once equilibrium was reached, the barriers were moved toward each other which reduced the surface area and increased
. As this happened, the brighter areas of the film appeared to condense so that at
max the film looked fuzzy and gel like (Fig. 8) . Important from these data is that the film is not homogenous, but comprises domains which presumably contain higher concentrations of lipids and other domains that contain higher concentrations of proteins.
|
eq after adsorption compared with that obtained with purified Tlc. This was the case for both bovine and human Meibomian lipid films (Fig. 7) . By contrast, lipidation of purified Tlc was expected to add NBD-cholesterol to Tlc and/or replace some of the lipids already bound to Tlc with NBD-cholesterol. Therefore, it was expected that more molecules would be added to surface during adsorption, resulting in a higher
eq. This was observed with adsorption to bovine Meibomian lipids, but not with adsorption to human Meibomian lipids. Indeed,
eq was substantially less (Fig. 7) .
Theoretically, relipidation of delipidated Tlc should have loaded it with NBD-cholesterol, hence a
eq similar to that of purified Tlc was expected after adsorption. This was observed with adsorption to a bovine Meibomian lipid film, but not with human Meibomian lipid film (Fig. 7) . Adsorption of relipidated Tlc to human Meibomian lipid film resulted in a
eq that was comparable with that obtained with delipidated Tlc (Fig 7) , and far lower than that obtained with purified Tlc.
After
eq had been reached, isocycles were performed on the protein adsorbed Meibomian lipid films. There were no significant differences with respect to different forms of Tlc (purified, delipidated, lipidated, and relipidated) for the isocycles of bovine Meibomian lipid films (Fig. 5) . However, there were large differences for human Meibomian lipid films (Fig. 5) . Hysteresis was less and it was similar to that of Meibomian lipid films alone.
max was quite low compared with the purified Tlc adsorbed film.
max for lipidated and delipidated Tlc adsorbed films were similar, and for relipidated Tlc adsorbed films, it was further reduced (Fig. 5) .
Like purified Tlc, the adsorption of delipidated Tlc to a human Meibomian lipid film was markedly different from the adsorption to a bovine Meibomian lipid film (Figs. 9 and 10) . Adsorption to a human Meibomian lipid film initially gave dark small patches in the film followed by larger dark areas at
eq. Isocycles caused the dark patches to become condensed and then distinct dark gray and bright areas were seen at higher pressures. Adsorption of delipidated Tlc to a bovine Meibomian lipid film initially resulted in the formation of a few very dark regions and gray zones. The dark regions disappeared and the gray zones coalesced to form squiggly patterns in the film. During isocycles, these squiggly patterns remained even at high pressures (Fig. 11) which was different from the equivalent human Meibomian lipid film in which, during isocycles, small dark patches appeared in the film (Fig. 9) .
|
|
|
For some of the adsorption experiments using lipidated and relipidated Tlc, the appearance of the surface outside the barriers (at an air buffer interface with no lipid) was observed. The fluorescence was very weak, and the film was very mobile and had a slightly stripy appearance (Figs. 12 and 13) , similar to that described above. A striking feature of adsorption of lipidated Tlc to a Meibomian lipid film held at 10 mN/m was that the appearance of the human Meibomian lipid film was very different from the bovine Meibomian lipid film. A main feature of adsorption to a human Meibomian lipid film was the appearance of diffuse bright spots (not crystals) which became smaller with time (Fig. 12) . This was not seen during adsorption to a bovine Meibomian lipid film (Fig. 13) , nor with adsorption of relipidated Tlc to a human Meibomian lipid film (Fig. 12) . During isocycles, these spots were not present at low pressures, but reappeared at higher pressures. Adsorption to a bovine Meibomian lipid film by lipidated Tlc caused a type of clumping of fluorescent areas. During isocycles, these clumps were pushed together at higher pressures to form larger aggregations, and these broke up into smaller aggregates at lower pressure. For relipidated Tlc, the fluorescence was diffuse for the bovine Meibomian lipid film and there were distinct regions of fluorescence. For a human Meibomian lipid film, adsorption of relipidated Tlc resulted in a very diffuse film and at
eq the film was honeycombed with less intense fluorescent regions. This was very similar in appearance to the film at the end of adsorption with delipidated Tlc (Fig. 9) . On compression of a human Meibomian lipid film after adsorption of relipidated Tlc, diffuse spots, similar to those obtained for lipidated Tlc, could be seen in some regions (Fig. 12) .
|
|
| Discussion |
|---|
|
|
|---|
One of the most surprising results was the marked difference in the interaction of Tlc with human Meibomian lipid films and bovine Meibomian lipid films. This was unexpected because the overall composition of bovine and human Meibomian lipids is reportedly similar, with differences being mainly in the detail, such as the length of the fatty acid or fatty alcohol chains, and differences in their relative polar lipid composition (13.3% in human, 1.7% in bovine) and hydrocarbon composition (7.5% in human and 0.1% in bovine27 ). It is also unlikely that the method for collecting the Meibomian lipids could account for this difference because in both cases the lipids were collected by hard expression. It should be noted that in preliminary studies to these experiments, our analysis of gentle versus hard expressed lipids from bovine samples or humans (not reported) revealed no difference in composition. Indeed, high levels of phospholipids found in cell membranes would have been expected if the hard expression contained cellular material due the holocrine nature of the glands, but this was not the case.
Extrapolating these results means that although animal Meibomian lipids are excellent for developing experimental methodologies and providing background data, extreme caution has to be used in drawing direct conclusions about human Meibomian lipids from the animal models. It also implies that subtle differences in Meibomian lipid composition between people may result in profound differences in performance of this layer. A strong indication for this comes from the differences in isocycles of human Meibomian compared with the bovine Meibomian lipid films after adsorption of the various forms of Tlc. An initial mechanism for determining the relative importance of particular lipids to the behavior of the lipid films and how they interact with Tlc would be to compare the performance Meibomian lipid films from individuals rather than a pooled sample. Should there be differences between individuals, then it would necessary to carry out detailed lipid analysis on the same samples to identify critical differences. An alternative experiment would be to seed a pooled sample of human Meibomian lipids with different specific lipids—for example, a fatty acid such as oleic acid—in progressively higher ratios.
In contrast to the differences seen using the different lipid layers, temperature had little effect. The small changes in the isocycle curves and Tlc penetration curves could be attributed to a higher kinetic energy at higher temperatures.
HPLC-MS analyses of the lipids extracted from purified Tlc samples showed detectable amounts of nonpolar compounds similar in their HPLC and MS behavior to diacylglycerols (see below). However, samples clearly had varying amounts of contaminations due to contact with plastic-containing products, even when the lipid extraction itself was done in glass/Teflon vials. This indicates some leaching of plastics occurs even in an aqueous environment and that Tlc can adsorb these plastic contaminants. The unique fragmentation pattern of the compounds with m/z values of 663 in the positive ion mode, and a strong signal m/z 473 detected in the negative ion mode clearly identified it as an oxidized form of Irgafos 16824 —a common additive used in production of polyethylene and other polymers. The second compound, which had m/z value of 637, is also related to the same group of additives. Without fragmentation of the extracts, it is likely that we would have drawn an erroneous, but nevertheless satisfying conclusion that these were additional diacylglycerols based on expected results.
Our studies of the lipid extracts from Tlc revealed a relatively simple complement of predominantly diacylglycerols (tentatively identified as 1-palmitoyl-2-stearoyl-glycerol and 1,2-distearoyl-glycerol), based on the fragmentation patterns of peaks with m/z values of 607 and 579. This differs from what has been previously published. Glasgow et al.1 found a broad array of lipids including fatty acids, cholesterol, and phospholipids. This could be due to differences in procedure; for example, the lack of phospholipids in our sample could have been due to ion exchange used to separate Tlc from LF and LZ because theoretically it is possible that this also removed ionic lipids such as phospholipids. This needs to be followed up in the future, by examining the lipid composition of the ion exchange resin retentates.
The difference in how the lipidated and relipidated Tlc adsorbed to Meibomian lipid films compared with purified Tlc could be due to the nature of the bound lipids. The lipidated and relipidated forms have predominantly NBD-cholesterol bound. So in addition to the nature of the lipid film being important (bovine versus human), it appears that the interaction of Tlc with the lipid layer strongly depends on the lipids bound. Added to this is the speculation from above that there are different isoforms of Tlc and these may behave quite differently. A limitation of these experiments was that the binding of cholesterol to Tlc was not quantified, and nor was the degree of its binding into the lipid binding pocket of Tlc19 measured. This would be a useful modification for future experiments, as would loading of Tlc with other lipids such as fatty acids. A further complexity to be considered is the interaction with other proteins as well. There is good evidence that Tlc strongly interacts with LF and LZ and may exist, partly at least, as oligomers with these.8 One would expect that this would also affect the adsorption of Tlc to the lipid layer, and this should be examined in future studies.
Compared with isocycles of other proteins (bovine serum albumin, LZ, LF)28 applied to the surface with no lipids present, Tlc was remarkably stable at the surface, as indicated by only minor changes in the
-A isocycle curves with time and changes in temperature. This indicates that there is very little change in conformation or in organization of Tlc molecules when it is at the air liquid interface in the absence of a lipid film. Adsorption of Tlc to a Meibomian lipid layer spread on the surface and isocycles after adsorption indicate that Tlc was able to penetrate the film and not just interact with lipids at the aqueous lipid interface. In particular, this was indicated by the increase in
max. The temperature at which these adsorption experiments were carried out had little effect on penetration other than some kinetic changes (stiffness of film). The adsorption of purified Tlc to a human Meibomian lipid film is much slower (
10 times less) than for LZ or LF (Mudgil P, et al. IOVS 2007;48:ARVO E-Abstract 436; time for
eq at 37°C for LZ = 1000 s, for LF = 3000 s, but
max was less
25 mN/m). An interesting mechanistic reason for such slow penetration comes from a recent study which showed that there is an ionic binding site deep within the binding pocket of Tlc.29 This is capable of binding to fatty acids through their carboxyl group, albeit weakly. If it is assumed that free fatty acids are at the lipid aqueous interface, then Tlc might use this ionic interaction with the fatty acids as an initial phase for adsorption. Since this is weak binding, adsorption would be slow. Whether the differences between the rate of adsorption of Tlc to a Meibomian lipid layer and that of LZ or LF have a physiological relevance still needs to be determined because the concentration of these proteins in tears is at least 100 times greater than used here and presumably these proteins are continuously in contact with the lipid layer (do not have to diffuse through the subphase). Moreover, the presence of LZ or LF might also influence the adsorption of Tlc to a Meibomian lipid layer.
The presence of a human Meibomian lipid layer also seemed to facilitate adsorption of purified Tlc, particularly compared with no lipid layer. This was indicated both by the comparative changes in
eq with and without lipids on the surface, and the appearance of Tlc outside the barriers compared with its appearance inside the barriers in the presence of a lipid layer. In particular, the changes to the appearance of the films after adsorption of the various forms of Tlc indicate that Tlc itself is adsorbing to the lipid layer and not simply releasing cholesterol in the case of lipidated and relipidated Tlc. If this were the case, we would have expected that during isocycles under high pressure, crystals of cholesterol would form and once formed they would not dissipate at low pressures, and this was not the case.
| Footnotes |
|---|
Submitted for publication March 30, 2008; revised May 22 and August 4, 2008; accepted October 27, 2008.
Disclosure: T.J. Millar, None; P. Mudgil, None; I.A. Butovich, None; C.K. Palaniappan, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Thomas J. Millar, LZ118, Parramatta campus (North), Locked Bag 1797, Penrith South DC, NSW 1797, Australia; t.millar{at}uws.edu.au.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H Mochizuki, M Yamada, S Hatou, and K Tsubota Turnover rate of tear-film lipid layer determined by fluorophotometry Br J Ophthalmol, November 1, 2009; 93(11): 1535 - 1538. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |